European Commission secures EU access to Remdesivir for treatment of COVID-19

Jul 28, 2020

European Commission Press release Brussels, 29 Jul 2020 Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir.


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.